The mRNA vaccine candidate developed by BioNTech and Pfizer. Photo: Handout The mRNA vaccine candidate developed by BioNTech and Pfizer. Photo: Handout
The mRNA vaccine candidate developed by BioNTech and Pfizer. Photo: Handout

exclusive | Fosun hopes to launch BioNTech and Pfizer’s Covid-19 vaccine in China at the same time as US and Europe, Guo Guangchang says

  • The mRNA vaccine has been developed by German next-generation immunotherapy company BioNTech and US pharmaceutical firm Pfizer
  • Fosun has agreed to pay up to US$135 million towards the vaccine’s development and for exclusive rights for China, Taiwan, Hong Kong and Macau

Topic |   Fosun Group
The mRNA vaccine candidate developed by BioNTech and Pfizer. Photo: Handout The mRNA vaccine candidate developed by BioNTech and Pfizer. Photo: Handout
The mRNA vaccine candidate developed by BioNTech and Pfizer. Photo: Handout
READ FULL ARTICLE